ellen strahlman  glaxosmithkline plc  zoominfocom   bdx ellen r strahlman insider trades for becton dickinson  co bulletin investor alert new york markets after hours market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close becton dickinson  co nyse bdx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus becton dickinson  co after hours  quotes are delayed by  min jul    pm bdx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high 9   week low  week high   insider activity individual ellen r strahlman dr ellen r strahlman md is chief medical officer evpresearch  development at becton dickinson  co she is on the board of directors at losonoco ltd and syncona partners llp dr strahlman was previously employed as chief medical officer  senior vice president by glaxosmithkline plc chief medical officer  global headresearch by bausch  lomb inc a principal by merck  co inc a principal by novartis corp and vice presidentworldwide business development by pfizer inc she received her undergraduate degree from harvard university a graduate degree from the johns hopkins bloomberg school of public health and a doctorate degree from the johns hopkins university school of medicine transactions date shares transaction value     award at  per share      derivativenonderivative trans at  per share      award at  per share      disposition at  per share 9     derivativenonderivative trans at 9 per share      award at  per share   9   award at  per share   9   award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr vincent a forlenza chairman  chief executive officer mr thomas polen president mr christopher r reidy evp chief financial  administrative officer dr ellen r strahlman chief medical officer evpresearch  development mr aaron pettit chief ethics compliance officer  senior vp ms helena bragd general managernordisk region mr david w highet chief intellectual property counsel  vp mr alexandre conroy presidenteurope ema  american region mr pierre boisier senior vice presidentquality mr stephen sichak senior vice presidentintegrated supply chain ms patti e russell senior vp chief ethics  compliance officer ms patricia a walesiewicz assistant secretary mr gary m cohen presidentglobal health  executive vp mr john e gallagher treasurer controller  senior vpfinance mr nabil shabshab chief marketing officer  evpstrategic planning ms antoinette f segreto vice presidenttax mr troy kirkpatrick headmedia relations ms lindsay roman senior managerpublic relations ms monique n dolecki vice presidentinvestor relations ms linda tharby chief human resource officer  vice president mr gary m defazio secretary  senior vice president mr richard j naples chief regulatory officer  executive vp mr jeffrey s sherman executive vice president  general counsel mr r andrew eckert independent director dr claire m fraserliggett independent director dr claire pomeroy independent director ms catherine m burzik independent director ms rebecca w rimel independent director mr christopher ian montague jones independent director mr willard j overlock independent director mr basil l anderson independent director mr james f orr independent director mr gary a mecklenburg independent director mr marshall o larsen independent director mr bertram l scott independent director trending tickers quoteszigman9composite vuzi quoteszigman9composite jcp quoteszigman99composite nugt9 quoteszigman9composite jnug9 quoteszigmancomposite tlt x powered by log in 9 pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwhy it might be time to invest in the companies amazon is destroying pbitcoin investors things may get very ugly soon if this chart overlay is right pmeet the ‘hamilton’ actors who fly crosscountry when a cast member can’t go on pdonald trump just ousted reince priebus what to do if you think you’re about to get fired phere’s what to do if like reince priebus you’re suddenly out of a job preince priebus departs as chief of staff as trump gives job to john kelly pthe perils and pleasures of blocking friends and colleagues on social media pwhat’s really happening with target’s cartwheel app pwall street isn’t ready for a point tumble in the dow industrials pbreakingin a tweet trump names gen kelly his new chief of staff pmattel could get wrecked by weak ‘cars ’ toy sales pthis  number sums up why that foxconn deal is overthetop bad for wisconsin pbreakingtrump tweets hes named a new chief of staff john kelly pwall street isn’t ready for a point tumble in the dow industrials plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss loading more headlines dow quoteszigman9realtime    nasdaq quoteszigman9realtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml   9 virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml  99 99 lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  ellen strahlman becton dickinson  company chief medical officer  evp research  development  redbooks brands marketers agencies search less sell more    sign in get a free trial    contact us  9 ellen strahlman chief medical officer  evp research  development becton dickinson  company email realtime sales trigger feed  generated by redbooks machine learning and natural language processing technology tracking  news sources to aggregate all new executives jobrole changes and news on decision makers brands and agencies in the mediamarketing industry this sales feed is for ellen strahlman at becton dickinson  company ellen strahlman works as chief medical officer  evp research  development  acting in a dataprivacy role  becton dickinson  company is a leader in pharmaceuticals  health care products  redbooks tracks personnel changes for advertisers spending over  million annually for more dataprivacy leads or mediamarketing prospecting automation start a free trial now recent related news  gcmi launches new medtech accelerator  selected accelerator companies will live at gcmi for  to  months depending on the milestones created at admission and the tasks to be completed during their stay “in spite of best efforts medtech startups still face ‘a valley of death’ when it comes to securing funding and bringing the first product to market” stated ellen strahlman md mhsc executive vice president rd and chief medical officer for bd “gcmi represents a unique way to address that issue and the program dovetails nicely with bd’s global accelerator partnerships people in this article ellen strahlman  bacit  change of name  the isin and sedol numbers for the ordinary shares will remain unchanged in addition the company is pleased to announce that the appointment of nigel keen and ellen strahlman as nonexecutive directors of the company is effective today nigel keen currently acts as director of deltex medical group plc and has previously acted as director of bioquell plc laird plc and oxford instruments plc  people in this article ellen strahlman learn more about ellen strahlman and  key contacts   create targeted lead lists   gain insider knowledge with advanced machine  learning   realtime verified contact info enter work email please enter email address please enter valid email address learn more about ellen strahlman and  key contacts first name  please enter first name last name  please enter last name company name  please enter company name email  phone  please enter phone number please enter  digits number what industry are you in    please select one the categories below please enter value for the industry  media sales  production  adtechmartech  sponsorship sales   agency new business   other what is your role    please select one the categories below please enter value for the role   csuite   vpmanager   sales rep   other thank you for registering for a free redbookscom trial we are processing your request and will be in touch shortly to get you started for immediate assistance please call us at  9 or email us at inforedbookscom home learn more free trial features ad think events thought leadership events top advertiser directory top agency directory add your agency update your agency agency showcase advertising associations creative spotlight services and suppliers about us blog contact us jobs terms  conditions privacy policy customer support  9 connect with us copyright   red books llc all rights reserved ellen strahlman md mhsc  ois ellen strahlman md mhsc chief medical officer becton dickinson and company back to previous page biography dr ellen strahlman is currently chief medical officer for becton dickinson and company she was previously senior vice president office of the ceo and global head neglected tropical diseases for glaxosmithkline in this capacity she led the company’s many programs and activities in global health served on the board of directors for viiv healthcare plc was the senior executive advisor to the ceo future strategy group vaccines public health program and pulse volunteer program and provided specific support to the ceo for medical matters relating to public health access to medicine programs corporate development activities and other external engagement efforts ellen joined gsk in august  as the chief medical officer for the company in this role as the most senior physician leader of the company she had primary responsibility for matters of patient safety general medical governance medical ethics and integrity medical information and investigations involving human subjects relating to any gsk product pharmaceutical biological and consumer healthcare medicinal products in development and on the market she was appointed to her new role in the office of the ceo in march  prior to joining gsk ellen was vice president worldwide business development at pfizer earlier in her career ellen held senior leadership positions at bausch  lomb merck  co and more recently at novartis and virgoen ltd accompanying her work in industry ellen has been a champion and spokesperson for public health and world heath issues including hiv and blinding eye diseases she is a graduate of harvard university biochemical sciences and applied mathematics and obtained her medical degree from the johns hopkins school of medicine she has medical qualifications in general surgery and ophthalmology together with a masters degree in health sciences latest news double shot gives spark therapeutics a joltinotek may be for sale but who will buy about ois events news videos ois podcast ois index contact us call us 9 get involved sponsorship opportunities presenting companies companies to watch media  press advertise with ois be our podcast guest upcoming events oisasrs  oisaao  connect with us facebookgooglelinkedintwitteryoutube httpswwwgoogletagmanagercomnshtmlidgtmtdtwf height width styledisplaynonevisibilityhidden ellen strahlman  the bmj skip to main content this site uses cookies more info close by continuing to browse the site you are agreeing to our use of cookies find out more here close subscribe my account my email alerts bma member login login username  password  forgot your sign in details need to activate bma members sign in via openathens sign in via your institution edition us uk south asia international our company toggle navigation the bmj logo site map search search form searchsearch advanced search search responses search blogs toggle top menu ellen strahlman ellen strahlman md mhsc is the executive vice president for research and development and chief medical officer for bd becton dickinson and company in this role she oversees the company’s innovation system research  development rd and medical affairs functions as an officer of the company she is the mc cochair of the science marketing innovation and technology committee for the bd board of directors and she serves as a member of the company’s management committee mc corporate business development team corporate ethics steering team and the bd leadership team in her management capacity ellen cochairs the company’s innovation and new product development council chairs the rd and the medical affairs leadership teams and leads the office of science medicine  technology for bd comprising more than  associates worldwide dr strahlman joined bd in may  from glaxosmithkline  having served as the senior vice president and chief medical officer since  in addition to working in the office of the ceo as senior medical advisor and global head of neglected tropical diseases as gsk’s chief medical officer dr strahlman had accountability for medical safety and patient matters for all programs in development and commercialized products in the vaccines pharmaceutical and consumer businesses as well as organizational responsibility for activities that included medical affairs regulatory affairs clinical safety and other areas prior to glaxosmithkline dr strahlman held executive leadership roles at merck novartis pfizer and bausch  lomb that included oversight of the development licensing and commercialization of proprietary and generic pharmaceuticals vaccines drug delivery systems consumer products and medical devices throughout her career ellen has and continues to be a passionate advocate for the democratization of technology and access to highquality healthcare and has worked to create business solutions designed to deliver medicines products and services on a global basis  she currently serves on the board of directors for sycona partners llp the advisory boards for the british medical journal and the johns hopkins bloomberg school of public health health advisory board and in november  she became a fellow of the salzburg global seminars a nonprofit organization that holds seminars that strive to challenge present and future leaders to solve issues of global concern past roles include serving on the board of directors for viiv healthcare plc industry representative on the fdacder dermatologic  ophthalmic drug advisory committee who partnership for disease control initiatives un commission on lifesaving commodities for women  children and the healthcare coalition for the international centre for missing  exploited children ellen is a graduate of harvard university biochemical sciences and obtained her medical degree from the johns hopkins school of medicine she has medical qualifications in general surgery johns hopkins and ophthalmology the wilmer institute johns hopkins finally ellen earned her masters degree in health sciences from the johns hopkins bloomberg school of public health as a carnegiemellon physician public health fellow see ellen strahlmans declaration of interests form this weeks poll read related article see previous polls ellen strahlman skip navigationabout dean searchschool at a glancebloomberg american health initiativehistorycentennialwhat is public healthdean klags cornerfaculty directorylecture serieshonors  awardsschoolwide initiativesoffices  servicesdirections  mapsevent calendarcareerscontact usacademics degree programscertificate programscontinuing  executive educationonline learning  coursesopencoursewareresidency programspostdoctoral trainingcourse catalogacademic calendarfaculty directoryfaculty recognition lecture seriesoffice of academic affairsadmissions how to applyinternational applicantstuition  feesfinancial aidfunding opportunitiesfunding resourcesscholarshipsvisitconnect with current studentsconnect with facultymeet jhsph in your areacontact admissionsdepartments biochemistry and molecular biologybiostatisticsenvironmental health and engineeringepidemiologyhealth behavior and societyhealth policy and managementinternational healthmental healthw harry feinstone dept of molecular microbiology and immunologypopulation family and reproductive healthresearch centers  institutesglobal projectsinstitutional review boardfaculty directoryscival experts research profilesscival fundingstudent life events  activitieshousingdiningfitness centerinternational studentscareer servicesvisitlife in baltimoreoffice of student lifestudent assemblysource student outreach resource centersustainabilitytransportationgraduationoffice of student affairspractice  training practice for facultypractice for studentspractice for professionalscontinuing educationcontact usonline trainingsgraduate training programs in clinical investigationmid‑atlantic regional public health training centernews about usnews releasesstoriessocial mediagiving make a gifthow your gift helpsdonor storiesrising to the challengecontact usfaqs search terms search johns hopkins bloomberg school of public health protecting health saving lives—millions at a timehealth advisory board home overview board members committee structure philanthropic impact office directory members only in memoriam da henderson  home  about  school at a glance  health advisory board  board members  ellen strahlman  ellen strahlman md mhsc senior vice president research  development chief medical officerellen strahlman md mhsc is a senior executive with  years of international experience in the healthcare industry biopharmaceuticals medical devices public health  she is currently the senior vice president research  development and chief medical officer and for becton dickinson and company a leading global medical technology companydr strahlman reports to bd’s ceo vincent forlenza and has accountability for the company’s innovation system as well as rd and medical affairs functions  as an officer of the company she serves on the ceo’s management committee worldwide operating committee the bd leadership team corporate business development team corporate ethics steering team and centerpoint steering team   in her management capacity she cochairs the company’s innovation council chairs the rd management committee and the medical affairs leadership team and leads the newly established office of science medicine  technology for bddr strahlman joined bd in may  from glaxosmithkline plc having served as the senior vice president and chief medical officer cmo since  and also working in the office of the ceo as senior medical advisor and global head of neglected tropical diseases  as gsk’s cmo dr strahlman had accountability for medical safety and patient matters for development programs and commercialized products in the vaccines pharmaceutical and consumer businesses as well as organizational oversight for activities that included medical affairs product development clinical safety and pharmacovigilance regulatory affairs quality and compliance   known for her scientific and patientcentric leadership across the continuum of product ideation development and commercialization dr strahlman has led teams developing pharmaceuticals medical devices generics and consumer products in nearly every therapeutic category since 9  she has served at the executive level in roles leading rd medical affairs scientific affairs and business development organizations her executive experience includes leadership roles at merck bausch  lomb novartis pfizer and gsk and she has also worked as a biotech ceothroughout her career ellen has and continues to be a passionate advocate for global heath and has worked to create business solutions designed to deliver equitable global access to highquality healthcare services  wellversed in global health and international policy ellen has served as corporate liaison to the press media and government agencies on a variety of medical and healthcare system related issues as a spokesperson for the industry and biotechnology she has addressed issues of public health and corporate social responsibility in the healthcare industrial sector ellen is a graduate of harvard university biochemical sciences and obtained her medical degree from the johns hopkins school of medicine  she has medical qualifications in general surgery johns hopkins and ophthalmology the wilmer institute johns hopkins finally ellen earned her masters degree in health sciences from the johns hopkins bloomberg school of public health as a carnegiemellon physician public health fellowjohns hopkins bloomberg school of public health  n wolfe street baltimore md contact us directions  maps calendars offices  services online learning  courses careers accreditation web policies feedbackjhsph alumni myjhsphedu courseplus student information system sis myjhuedulike us on facebook follow us on twitter watch videos on youtube follow us on instagram connect with linkedinjohns hopkins university ellen strahlman md mhsc  exponential medicine  november  navigation exponential medicine  november  exponential medicine  november  ellen strahlman md mhsc ellen strahlman md mhsc chief medical officer becton dickinson ellen strahlman md mhsc is the executive vice president for research and development and chief medical officer for bd in this role she oversees bds innovation system and the rd and medical affairs functions as an executive officer of the company she cochairs the science marketing innovation and technology committee for the bd board of directors cochairs bds innovation and new product development council and she leads the office of science medicine  technology for bd comprising more than  associates worldwide throughout her career ellen has and continues to be a passionate advocate for “innovation and access” in the healthcare industry leading teams that provide the democratization of technology and access to highquality healthcare she has worked to create business solutions designed to deliver medicines products and services on a global basis dr strahlman joined bd in may  from glaxosmithkline  having served as the senior vice president and chief medical officer since  as gsk’s chief medical officer dr strahlman had accountability for medical safety and patient matters for all programs in development and commercialized products in the vaccines pharmaceutical and consumer businesses prior to glaxosmithkline dr strahlman held executive leadership roles at merck novartis pfizer and bausch  lomb she currently serves on the board of directors for syncona partners llp advisory boards for the british medical journal and the johns hopkins bloomberg school of public health and is a fellow of the salzburg global seminars ellen is a graduate of harvard university and the johns hopkins school of medicine she has medical qualifications in general surgery johns hopkins and ophthalmology the wilmer institute johns hopkins finally ellen earned her masters degree in health sciences from the johns hopkins bloomberg school of public health as a carnegiemellon physician public health fellow view more exponential medicine faculty exponential medicine brings together top experts to inform medical leaders how technology is impacting business view the full list of  faculty view all faculty contact us for press inquires partnerships or for general inquiries contact us for group sale information contact group sales platinum partner platinum partner of singularity university summits